click
Contact

Leveraging a Humanized SLE Mouse Model to Evaluate Next-Generation Immune-Cell-Targeted Therapeutics (Download)

Leveraging a Humanized SLE Mouse Model to Evaluate Next-Generation Immune-Cell-Targeted Therapeutics (Download)

Facebook
LinkedIn
Fill out the form below to download this content.
Leveraging-a-Humanized-SLE-Mouse-Model-to-Evaluate-Next-Generation-Immune-Cell-Targeted-Therapeutics

Leveraging a Humanized SLE Mouse Model to Evaluate Next-Generation Immune-Cell-Targeted Therapeutics

Name(Required)
By clicking submit you consent to receive email communications about products and services of Medicilon and are in accordance with our Privacy Policy. You may opt out at any time.
Contact

Search Medicilon

Preclinical CRO

Medicilon Congratulates : MindRank AI-Developed Oral GLP-1 MDR-001 Secures Up to RMB 1.75 Billion Exclusive Commercialization Deal with Sunshine Mandi

Read more
Preclinical CRO

A Note of Appreciation, A Mark of Recognition | Medicilon Supports Partner Tasly in Obtaining Clinical Trial Approval for TSL2402 Tablets

Read more
Preclinical CRO

BIOJAPAN 2026

Read more

Contact Medicilon

Name(Required)
Address(Required)